pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,692 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: filing×type: grant×type: phase readout×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa213
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Ophthalmology5

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06825897: Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe

    Sponsor: Santiago Ortega Gutierrez. Phase: NA. Conditions: Stroke, Acute

    full page →ctgov ↗
    ›AVAILABLEphase readoutNCT04159597: Expanded Access to Upadacitinib

    Sponsor: AbbVie. Phase: . Conditions: Crohn Disease, Ulcerative Colitis, Idiopathic Arthritis (Including sJIA, pJIA, or JPsA), Atopic Dermatitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06658197: Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke

    Sponsor: Xuanwu Hospital, Beijing. Phase: PHASE3. Conditions: Stroke, Ischemic, Stroke, Acute, Thrombosis, Brain, Drug Effect

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07216560: First-in-human Study of 7MW4911 in GI Cancer

    Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.. Phase: PHASE1. Conditions: GI Cancers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07461220: Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy

    Sponsor: Integrative Research Laboratories AB. Phase: PHASE1. Conditions: PARKINSON DISEASE (Disorder), Apathy, Safety

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05600920: A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Idiopathic CD4 Lymphopenia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05634720: Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer

    Sponsor: Duke University. Phase: PHASE4. Conditions: Pancreatic Ductal Adenocarcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05571982: Comparison of the Efficacy of Tidal Volume Breathing and Vital Capacity Breathing During High-flow Nasal Oxygen

    Sponsor: Yonsei University. Phase: NA. Conditions: Adult Patients 20 Years of Age or Older Who Are Planning to Undergo Surgery Under General Anesthesia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06384924: Raman Spectroscopy and Skin Cancer

    Sponsor: Tiezhi Zhang. Phase: . Conditions: Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07622459: Circadian Feeding and Reciprocal Scent Intervention in NICU

    Sponsor: Inonu University. Phase: NA. Conditions: Prematurity, Mechanical Ventilation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03325959: Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome

    Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: Fibromyalgia, Hyperbaric Oxygen

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07469059: Characterization of Renal Microvascular Alterations in Patients With Active Urinary Sediment and/or Proteinuria Using Ultrasound Localization Microscopy

    Sponsor: University of Erlangen-Nürnberg Medical School. Phase: . Conditions: Nephritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06587880: The Effect of Different Types of Mouthwash on Extraction Sockets' Healing

    Sponsor: University of Jordan. Phase: PHASE4. Conditions: Extraction Socket Healing, Quality of Life, Postoperative Complications

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03869996: Total Knee Arthroplasty: Fast Track Protocol is the Future?

    Sponsor: Istituto Ortopedico Rizzoli. Phase: NA. Conditions: Osteoarthritis, Knee, Arthropathy of Knee

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07604727: AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation

    Sponsor: University Medical Center Groningen. Phase: NA. Conditions: Atrial Fibrillation (AF), Heart Failure, Cardiac Pacing

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04716127: A Proximity-incentive Strategy for Cervical Cancer Screening

    Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Cervical Cancer, Uterine Cervical Disease, Human Papilloma Virus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05508061: Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

    Sponsor: Inreda Diabetic B.V.. Phase: NA. Conditions: Type 1 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02629042: Efficacy of Oral Prednisolone on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis

    Sponsor: University Hospital, Bordeaux. Phase: PHASE3. Conditions: Pulpitis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07624786: Patient-Ventilator Asynchrony: Occurence and Clinical Impact in Usual Care

    Sponsor: Erasmus Medical Center. Phase: . Conditions: Mechanical Ventilation, Patient-Ventilator Asynchrony

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06679270: Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

    Sponsor: Amryt Pharma. Phase: PHASE3. Conditions: Familial Partial Lipodystrophy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07214870: A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat

    Sponsor: Novo Nordisk A/S. Phase: PHASE1. Conditions: Fatty Liver Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07560969: Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African Americans

    Sponsor: University of Missouri, Kansas City. Phase: NA. Conditions: Diabetes, Physical Activity, Food Security, Nutrition Security

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07270783: Healthy Volunteer Study

    Sponsor: InventisBio Co., Ltd. Phase: PHASE1. Conditions: Healthy Volunteer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06456983: Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial

    Sponsor: Central Institute of Mental Health, Mannheim. Phase: NA. Conditions: Schizophrenia, Treatment Resistant Schizophrenia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04602741: Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Schizophrenia, Schizo Affective Disorder, Psychotic Disorders

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT03588754: Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?

    Sponsor: Yale University. Phase: PHASE2. Conditions: Alcohol Drinking

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06144554: Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

    Sponsor: Insulet Corporation. Phase: . Conditions: Type 1 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01581554: Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05012254: Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

    Sponsor: Fundación GECP. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07064005: Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.

    Sponsor: Pravat Mandal. Phase: PHASE1. Conditions: Parkinsons Disease (PD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07538505: Testing a Diabetes Care Program in Rural and Low-Income Clinics

    Sponsor: The University of Texas Medical Branch, Galveston. Phase: NA. Conditions: Type 2 Diabetes Mellitus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00340405: Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Lung Cancer

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT05924594: Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301

    Sponsor: Cingulate Therapeutics. Phase: PHASE3. Conditions: ADHD, ADHD - Combined Type, Attention Deficit Hyper Activity, Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder With Hyperactivity, Attention Deficit Hyperactivity Disorder Combined, Attention-deficit Hyperactivity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06253494: Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Endometrial Cancer, Cancer of Endometrium, Carcinoma of Endometrium, Endometrial Carcinoma

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05736666: Treadmill Perturbation Training for Fall Prevention After Total Knee Replacement

    Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: Knee Osteoarthritis, Arthroplasty Complications

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05168566: Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

    Sponsor: Teligene US. Phase: PHASE2. Conditions: Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07239466: A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

    Sponsor: Tao Zhang. Phase: PHASE2. Conditions: Rectal Cancer, Radiotherapy, Immunotherapy, Chemotherapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07529366: Pharmacist-Led Continuous Glucose Monitoring for Prediabetes

    Sponsor: University of South Florida. Phase: . Conditions: Prediabetes

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07409766: A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: EARLY_PHASE1. Conditions: Advanced Malignant Tumors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07355322: Comparison of a 3-step Bonding System (Transbond™ XT) and a 2-step System (GC Ortho Connect™) on Demineralization Around Maxillary Orthodontic Brackets

    Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Tooth Demineralization, White Spot Lesion, Demineralization, Orthodontic Appliance Complication, Dental Braces Complication

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06260722: Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07343622: Robot/Laparoscopic-Assisted Transanal Transection Duhamel Versus Modified Soave Pull-Through for TCA

    Sponsor: Zunyi Medical College. Phase: NA. Conditions: Total Colonic Aganglionosis, Hirschsprung Disease, Duhamel, Soave

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07446751: Long-term Outcomes of SMILE PRO for High Astigmatism

    Sponsor: Hanoi Medical University. Phase: NA. Conditions: High Astigmatism

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05972551: Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta

    Sponsor: Amgen. Phase: PHASE3. Conditions: Osteogenesis Imperfecta

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03726151: Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs

    Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Human Papillomavirus Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07523451: COMPARISON BETWEEN DIFFERENT CONCENTRATIONS OF OZONE GAS AS AN INTRA-ARTICULAR INJECTION FOR TREATMENT OF INTERNAL DERANGEMENT OF TEMPROMANDIBULAR JOINT

    Sponsor: Alexandria University. Phase: NA. Conditions: TMJ Disc Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05587751: Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Hormonal Gender-Affirming Therapy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07531251: Clinical Trial in Patients With Barth Syndrome- 4TAZPower

    Sponsor: Stealth BioTherapeutics Inc.. Phase: PHASE4. Conditions: Barth Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04410796: Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Metastatic Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06874296: Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time

    Sponsor: Charite University, Berlin, Germany. Phase: NA. Conditions: Liver Transplantation, Liver Diseases, Surgery

    full page →ctgov ↗
    ← prev
    page 61 of 94
    next →